Evidence map

TrialJournal of the American Heart Association2018

Interaction Between the Sodium-Glucose-Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects.

Christopher S Wilcox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

65 papers cite itlatest 60 shown

2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 29440005